Amanda's Absence: Should Vioxx Be Kept Off the Market?
Read the Fine Print
- Author:
- Dan Johnson
- Subject:
- Science and Technology, Social Sciences
- Institution Name:
- National Center for Case Study Teaching in Science
- Collection:
- Case Study Teaching in Science
- Grade Level:
- Post-secondary
- Grade Sub-Level:
- Community College - Lower Division, College - Upper Division
- Abstract:
When chronic pain forces a top student to withdraw from college, biology instructor Dr. Sharpe learns that medications (in this case, Vioxx) may be removed from the market for many reasons, including safety concerns. As the case unfolds, students learn how the FDA balances drug safety against medical needs. As written, the case is appropriate for a non-majors biology course. It could also be adapted for use in a more advanced course in cell biology, pharmacology, or biochemistry, or modified to explore statistical analysis, specific analytical methods used for risk/benefit analysis, or bioethical issues.
- Languages:
- English
- Material Type:
- Activities and Labs, Lesson Plans
- Media Format:
- Text/HTML, Downloadable docs
- Conditions of Use:
- Read the fine print
- Copyright Holder:
- National Center for Case Study Teaching in Science, University at Buffalo
Comments